{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:36:41Z","timestamp":1784180201078,"version":"3.55.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.bbi.2019.07.013","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T02:16:14Z","timestamp":1562724974000},"page":"152-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["S-adenosyl-l-methionine (SAMe), cannabidiol (CBD), and kratom in psychiatric disorders: Clinical and mechanistic considerations"],"prefix":"10.1016","volume":"85","author":[{"given":"M.","family":"Taylor Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthil Kumaran","family":"Satyanarayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack T.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mischoulon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2019.07.013_b0005","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/01.jcp.0000145339.45794.cd","article-title":"S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine","volume":"24","author":"Alpert","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbi.2019.07.013_b0010","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hep.22231","article-title":"S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation","volume":"47","author":"Ara","year":"2008","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.bbi.2019.07.013_b0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/15563650701241795","article-title":"Opioid receptors and legal highs: Salvia divinorum and Kratom","volume":"46","author":"Babu","year":"2008","journal-title":"Clin. Toxicol. (Philadelphia, Pa)"},{"key":"10.1016\/j.bbi.2019.07.013_b0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0002-9343(87)90858-8","article-title":"A new medical approach to the treatment of osteoarthritis. Report of an open phase IV study with ademetionine (Gumbaral)","volume":"83","author":"Berger","year":"1987","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbi.2019.07.013_b0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1515\/JPM.2006.077","article-title":"Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy","volume":"34","author":"Binder","year":"2006","journal-title":"J. Perinat. Med."},{"key":"10.1016\/j.bbi.2019.07.013_b0030","first-page":"92","article-title":"Ursodeoxycholic acid, S-adenosyl-L-methionine and their combinations in the treatment of gestational intrahepatic cholestasis (ICP)","volume":"71","author":"Binder","year":"2006","journal-title":"Ceska Gynekol."},{"key":"10.1016\/j.bbi.2019.07.013_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psc.2012.12.001","article-title":"Folate, vitamin B(1)(2), and S-adenosylmethionine","volume":"36","author":"Bottiglieri","year":"2013","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.bbi.2019.07.013_b0040","first-page":"905","article-title":"A randomized, double blind, placebo controlled trial of intravenous loading with S-adenosylmethionine (SAM) followed by oral SAM therapy in patients with knee osteoarthritis","volume":"21","author":"Bradley","year":"1994","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bbi.2019.07.013_b0045","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0002-9343(87)90854-0","article-title":"Italian double-blind multicenter study comparing S-adenosylmethionine, naproxen, and placebo in the treatment of degenerative joint disease","volume":"83","author":"Caruso","year":"1987","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbi.2019.07.013_b0050","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/1533317508325093","article-title":"Efficacy of a vitamin\/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension","volume":"23","author":"Chan","year":"2008","journal-title":"Am. J. Alzheimer's Dis. Other Dementias"},{"key":"10.1016\/j.bbi.2019.07.013_b0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2015\/968786","article-title":"Following the Roots of Kratom (Mitragyna speciosa): the evolution of an enhancer from a traditional use to increase work and productivity in southeast asia to a recreational psychoactive drug in western countries","volume":"2015","author":"Cinosi","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbi.2019.07.013_b0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jad.2015.12.045","article-title":"Cannabis use, depression and anxiety: a 3-year prospective population-based study","volume":"193","author":"Danielsson","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2019.07.013_b0065","first-page":"85","article-title":"Complementary and alternative medicine therapies for perinatal depression. Best practice & research","volume":"28","author":"Deligiannidis","year":"2014","journal-title":"Clin. Obstetrics Gynaecol."},{"key":"10.1016\/j.bbi.2019.07.013_b0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.yebeh.2016.05.024","article-title":"Evaluation of antiepileptic effect of S-adenosyl methionine and its role in memory impairment in pentylenetetrazole-induced kindling model in rats","volume":"61","author":"Dhediya","year":"2016","journal-title":"Epilepsy Behav.: E&B"},{"key":"10.1016\/j.bbi.2019.07.013_b0075","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/1531-8257(200011)15:6<1225::AID-MDS1025>3.0.CO;2-A","article-title":"S-Adenosyl-Methionine improves depression in patients with Parkinson's disease in an open-label clinical trial","volume":"15","author":"Di Rocco","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbi.2019.07.013_b0080","first-page":"9","article-title":"[Parenteral S-adenosylmethionine compared to placebos in the treatment of alcoholic liver diseases]","volume":"13","author":"Diaz Belmont","year":"1996","journal-title":"Anal. Med. Internal (Madrid, Spain 1984)"},{"key":"10.1016\/j.bbi.2019.07.013_b0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-8741(02)00252-0","article-title":"Anti-inflammatory and analgesic properties of the stem bark extract of Mitragyna ciliata (Rubiaceae) Aubrev. & Pellegr","volume":"84","author":"Dongmo","year":"2003","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbi.2019.07.013_b0090","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.eurpsy.2011.01.003","article-title":"SAMe and sexual functioning","volume":"27","author":"Dording","year":"2012","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.013_b0095","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts \u03b2-amyloid induced neuroinflammation by suppressing IL-1\u03b2 and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbi.2019.07.013_b0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0301-2115(96)02442-6","article-title":"S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial","volume":"67","author":"Floreani","year":"1996","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.bbi.2019.07.013_b0105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fpsyt.2017.00062","article-title":"Biochemical benefits, diagnosis, and clinical risks evaluation of kratom","volume":"8","author":"Fluyau","year":"2017","journal-title":"Front. Psychiatry"},{"issue":"Suppl 2","key":"10.1016\/j.bbi.2019.07.013_b0110","first-page":"122","article-title":"S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial","volume":"37","author":"Frezza","year":"1990","journal-title":"Hepato-gastroenterology"},{"key":"10.1016\/j.bbi.2019.07.013_b0115","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/hep.1840040217","article-title":"Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration","volume":"4","author":"Frezza","year":"1984","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.bbi.2019.07.013_b0120","first-page":"1098","article-title":"Prevention of S-adenosylmethionine of estrogen-induced hepatobiliary toxicity in susceptible women","volume":"83","author":"Frezza","year":"1988","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbi.2019.07.013_b0125","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s13311-017-0593-0","article-title":"S-adenosyl methionine and transmethylation pathways in neuropsychiatric diseases throughout life","volume":"15","author":"Gao","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbi.2019.07.013_b0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.fitote.2016.11.010","article-title":"Target regulation of PI3K\/Akt\/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis","volume":"116","author":"Giacoppo","year":"2017","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bbi.2019.07.013_b0135","first-page":"39","article-title":"Double-blind multicentre study of the activity of S-adenosylmethionine in hip and knee osteoarthritis","volume":"5","author":"Glorioso","year":"1985","journal-title":"Int. J. Clin. Pharmacol. Res."},{"key":"10.1016\/j.bbi.2019.07.013_b0140","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1124\/jpet.110.174268","article-title":"S-adenosylmethionine decreases lipopolysaccharide-induced phosphodiesterase 4B2 and attenuates tumor necrosis factor expression via cAMP\/protein kinase A pathway","volume":"337","author":"Gobejishvili","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2019.07.013_b0145","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/j.pain.0000000000000811","article-title":"Therapeutic benefits of the methyl donor S-adenosylmethionine on nerve injury-induced mechanical hypersensitivity and cognitive impairment in mice","volume":"158","author":"Gregoire","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.bbi.2019.07.013_b0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2017.03.007","article-title":"Patterns of Kratom use and health impact in the US-Results from an online survey","volume":"176","author":"Grundmann","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bbi.2019.07.013_b0155","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0031-6989(83)80040-X","article-title":"Anti-inflammatory activity of S-adenosyl-L-methionine: interference with the eicosanoid system","volume":"15","author":"Gualano","year":"1983","journal-title":"Pharmacol. Res. Commun."},{"key":"10.1016\/j.bbi.2019.07.013_b0160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neubiorev.2012.11.012","article-title":"From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction","volume":"37","author":"Hassan","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2019.07.013_b0165","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bbi.2019.07.013_b0170","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/03009749109096803","article-title":"Oral S-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation","volume":"20","author":"Jacobsen","year":"1991","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.bbi.2019.07.013_b0175","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1369-1600.2012.00483.x","article-title":"Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus","volume":"18","author":"Katsidoni","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.bbi.2019.07.013_b0180","article-title":"A review of antidepressant therapy in primary care: current practices and future directions","volume":"15","author":"Kennedy","year":"2013","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.bbi.2019.07.013_b0185","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.clinthera.2009.12.016","article-title":"Comparative clinical trial of S-adenosylmethionine versus nabumetone for the treatment of knee osteoarthritis: an 8-week, multicenter, randomized, double-blind, double-dummy, Phase IV study in Korean patients","volume":"31","author":"Kim","year":"2009","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bbi.2019.07.013_b0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0002-9343(87)90859-X","article-title":"A long-term (two years) clinical trial with S-adenosylmethionine for the treatment of osteoarthritis","volume":"83","author":"Konig","year":"1987","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbi.2019.07.013_b0195","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12974-016-0603-x","article-title":"Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells","volume":"13","author":"Kozela","year":"2016","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.bbi.2019.07.013_b0200","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1074\/jbc.M109.069294","article-title":"Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta\/STAT proinflammatory pathways in BV-2 microglial cells","volume":"285","author":"Kozela","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2019.07.013_b0205","doi-asserted-by":"crossref","DOI":"10.1002\/ejp.1377","article-title":"Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders","author":"Krebs","year":"2019","journal-title":"Eur. J. Pain Lond. Engl."},{"key":"10.1016\/j.bbi.2019.07.013_b0210","article-title":"Kratom, an emerging drug of abuse, raises prolactin and causes secondary hypogonadism: case report","volume":"6","author":"LaBryer","year":"2018","journal-title":"J. Invest. Med. High Impact Case Rep."},{"key":"10.1016\/j.bbi.2019.07.013_b0215","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.eurpsy.2011.03.006","article-title":"Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder","volume":"27","author":"Levkovitz","year":"2012","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.013_b0220","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3233\/JAD-170177","article-title":"S-adenosylmethionine attenuates oxidative stress and neuroinflammation induced by amyloid-\u03b2 through modulation of glutathione metabolism","volume":"58","author":"Li","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbi.2019.07.013_b0225","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.013_b0230","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0002-9343(87)90855-2","article-title":"Double-blind controlled clinical trial of oral S-adenosylmethionine versus piroxicam in knee osteoarthritis","volume":"83","author":"Maccagno","year":"1987","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbi.2019.07.013_b0235","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","article-title":"Practical considerations in medical cannabis administration and dosing","volume":"49","author":"MacCallum","year":"2018","journal-title":"Eur. J. Internal Med."},{"key":"10.1016\/j.bbi.2019.07.013_b0240","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2009.04.021","article-title":"Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation","volume":"51","author":"Magen","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbi.2019.07.013_b0245","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1476-5381.2009.00589.x","article-title":"Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation","volume":"159","author":"Magen","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbi.2019.07.013_b0250","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0168-8278(01)00208-2","article-title":"S-Adenosylmethionine modulates inducible nitric oxide synthase gene expression in rat liver and isolated hepatocytes","volume":"35","author":"Majano","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbi.2019.07.013_b0255","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0168-8278(99)80263-3","article-title":"S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial","volume":"30","author":"Mato","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbi.2019.07.013_b0260","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0741-8329(02)00224-0","article-title":"S-Adenosylmethionine, cytokines, and alcoholic liver disease","volume":"27","author":"McClain","year":"2002","journal-title":"Alcohol (Fayetteville, N.Y.)"},{"key":"10.1016\/j.bbi.2019.07.013_b0265","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000320288","article-title":"A case report of inpatient detoxification after kratom (Mitragyna speciosa) dependence","volume":"16","author":"McWhirter","year":"2010","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.bbi.2019.07.013_b0270","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nbd.2013.06.016","article-title":"Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors","volume":"59","author":"Mecha","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2019.07.013_b0275","doi-asserted-by":"crossref","first-page":"1158s","DOI":"10.1093\/ajcn\/76.5.1158S","article-title":"Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence","volume":"76","author":"Mischoulon","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbi.2019.07.013_b0280","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4088\/JCP.13m08591","article-title":"A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder","volume":"75","author":"Mischoulon","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.013_b0285","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41398-018-0191-x","article-title":"Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function","volume":"8","author":"Morgan","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.013_b0290","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0002-9343(87)90857-6","article-title":"Double-blind clinical trial of S-adenosylmethionine versus ibuprofen in the treatment of osteoarthritis","volume":"83","author":"Muller-Fassbender","year":"1987","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbi.2019.07.013_b0295","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2474-5-6","article-title":"S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495]","volume":"5","author":"Najm","year":"2004","journal-title":"BMC Musculoskeletal Disord."},{"key":"10.1016\/j.bbi.2019.07.013_b0300","unstructured":"National Institutes of Health, 2010. Fact Sheet: Complementary and Alternative Medicine. Retrieved from https:\/\/report.nih.gov\/NIHfactsheets\/Pdfs\/ComplementaryandAlternativeMedicine(NCCAM).pdf."},{"key":"10.1016\/j.bbi.2019.07.013_b0305","unstructured":"National Institute on Drug Abuse (NIDA), 2018. Kratom. Retrieved from https:\/\/www.drugabuse.gov\/publications\/drugfacts\/kratom on 2018, November 1."},{"key":"10.1016\/j.bbi.2019.07.013_b0310","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/appi.ajp.2009.09081198","article-title":"S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial","volume":"167","author":"Papakostas","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.013_b0315","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1152\/physiolgenomics.00056.2014","article-title":"S-adenosylmethionine mediates inhibition of inflammatory response and changes in DNA methylation in human macrophages","volume":"46","author":"Pfalzer","year":"2014","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.bbi.2019.07.013_b0320","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lfs.2019.03.053","article-title":"Cannabidiol: recent advances and new insights for neuropsychiatric disorders treatment","volume":"224","author":"Premoli","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.bbi.2019.07.013_b0325","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0169-328X(96)00245-8","article-title":"Beneficial effects of S-adenosyl-L-methionine on blood-brain barrier breakdown and neuronal survival after transient cerebral ischemia in gerbils","volume":"44","author":"Rao","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.bbi.2019.07.013_b0330","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3233\/JAD-142499","article-title":"A phase II randomized clinical trial of a nutritional formulation for cognition and mood in Alzheimer's disease","volume":"45","author":"Remington","year":"2015","journal-title":"J. Alzheimer's Dis.: JAD"},{"key":"10.1016\/j.bbi.2019.07.013_b0335","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1533317508325094","article-title":"Efficacy of a vitamin\/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study","volume":"24","author":"Remington","year":"2009","journal-title":"Am. J. Alzheimer's Dis. Other Dementias"},{"key":"10.1016\/j.bbi.2019.07.013_b0340","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/j.bbi.2011.07.111","article-title":"Cannabidiol produces a long-term anti-inflammatory effect in a murine model of acute lung injury","volume":"25","author":"Ribeiro","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.07.013_b0345","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1471-0528.2003.00029.x","article-title":"A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis","volume":"111","author":"Roncaglia","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.bbi.2019.07.013_b0350","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000288642","article-title":"Double-blind, placebo-controlled study of S-adenosyl-L-methionine in depressed postmenopausal women","volume":"59","author":"Salmaggi","year":"1993","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.bbi.2019.07.013_b0355","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.euroneuro.2018.07.098","article-title":"Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: an 8-week double-blind, randomized, controlled trial<sup\/>","volume":"28","author":"Sarris","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2019.07.013_b0360","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jad.2018.11.092","article-title":"Nutraceuticals for major depressive disorder- more is not merrier: an 8-week double-blind, randomised, controlled trial","volume":"245","author":"Sarris","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2019.07.013_b0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(87)90843-6","article-title":"Osteoarthritis: the clinical picture, pathogenesis, and management with studies on a new therapeutic agent, S-adenosylmethionine","volume":"83","author":"Schumacher","year":"1987","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbi.2019.07.013_b0370","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000226292","article-title":"Anti-inflammatory and antinociceptive effects of Mitragyna speciosa Korth methanolic extract","volume":"18","author":"Shaik Mossadeq","year":"2009","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.bbi.2019.07.013_b0375","doi-asserted-by":"crossref","first-page":"e656","DOI":"10.4088\/JCP.16r11113","article-title":"S-adenosylmethionine (SAMe) for neuropsychiatric disorders: a clinician-oriented review of research","volume":"78","author":"Sharma","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.013_b0380","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3233\/JAD-2008-13107","article-title":"S-adenosyl methionine: a natural therapeutic agent effective against multiple hallmarks and risk factors associated with Alzheimer's disease","volume":"13","author":"Shea","year":"2008","journal-title":"J. Alzheimer's Dis.: JAD"},{"key":"10.1016\/j.bbi.2019.07.013_b0385","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-244X-4-38","article-title":"S-adenosylmethionine (SAM-e) for the treatment of depression in people living with HIV\/AIDS","volume":"4","author":"Shippy","year":"2004","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.013_b0390","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainresbull.2016.05.004","article-title":"Traditional and non-traditional uses of Mitragynine (Kratom): a survey of the literature","volume":"126","author":"Singh","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbi.2019.07.013_b0395","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.drugalcdep.2017.08.034","article-title":"Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program","volume":"180","author":"Smith","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bbi.2019.07.013_b0400","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbi.2018.09.014","article-title":"Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPAR\u03b3 receptors","volume":"74","author":"Sonego","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.07.013_b0405","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbamcr.2004.12.001","article-title":"S-adenosylmethionine (SAMe) modulates interleukin-10 and interleukin-6, but not TNF, production via the adenosine (A2) receptor","volume":"1743","author":"Song","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbi.2019.07.013_b0410","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.euroneuro.2008.08.004","article-title":"Improvement of aggressive behavior and quality of life impairment following S-adenosyl-methionine (SAM-e) augmentation in schizophrenia","volume":"19","author":"Strous","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2019.07.013_b0415","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.drugalcdep.2017.10.012","article-title":"Kratom use and mental health: a systematic review","volume":"183","author":"Swogger","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bbi.2019.07.013_b0420","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1254\/fpj.87.507","article-title":"Effect of S-adenosyl-L-methionine (SAMe) on disturbances in hand movement and delayed response tasks after lesion of motor or prefrontal cortex in the monkey","volume":"87","author":"Takahashi","year":"1986","journal-title":"Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica"},{"key":"10.1016\/j.bbi.2019.07.013_b0425","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0014-4886(87)90256-1","article-title":"S-adenosyl-L-methionine facilitates recovery from deficits in delayed response and hand movement tasks following brain lesions in monkeys","volume":"98","author":"Takahashi","year":"1987","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbi.2019.07.013_b0430","first-page":"106","article-title":"Evaluation of S-adenosylmethionine in secondary fibromyalgia: a double-blind study","volume":"16","author":"Tavoni","year":"1998","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bbi.2019.07.013_b0435","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0002-9343(87)90862-X","article-title":"Evaluation of S-adenosylmethionine in primary fibromyalgia. A double-blind crossover study","volume":"83","author":"Tavoni","year":"1987","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbi.2019.07.013_b0440","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0024-3205(98)00075-7","article-title":"Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice","volume":"62","author":"Thongpradichote","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.bbi.2019.07.013_b0445","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1016\/j.bmcl.2004.07.081","article-title":"A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2\u20132H3]-salvinorin A","volume":"14","author":"Tidgewell","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbi.2019.07.013_b0450","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jep.2011.04.011","article-title":"Mitragynine inhibits the COX-2 mRNA expression and prostaglandin E(2) production induced by lipopolysaccharide in RAW264.7 macrophage cells","volume":"136","author":"Utar","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbi.2019.07.013_b0455","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/abbs\/gmx073","article-title":"Effects of cannabidiol interactions with Wnt\/beta-catenin pathway and PPARgamma on oxidative stress and neuroinflammation in Alzheimer's disease","volume":"49","author":"Vallee","year":"2017","journal-title":"Acta Biochim. Biophy. Sin."},{"key":"10.1016\/j.bbi.2019.07.013_b0460","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/00365528909093067","article-title":"Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease","volume":"24","author":"Vendemiale","year":"1989","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.bbi.2019.07.013_b0465","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0002-9343(87)90856-4","article-title":"Double-blind comparative clinical trial with S-adenosylmethionine and indomethacin in the treatment of osteoarthritis","volume":"83","author":"Vetter","year":"1987","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbi.2019.07.013_b0470","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0006-8993(00)02873-0","article-title":"Effect of S-adenosyl-L-methionine on rat brain oxidative stress damage in a combined model of permanent focal ischemia and global ischemia-reperfusion","volume":"883","author":"Villalobos","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2019.07.013_b0475","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/03009749709065682","article-title":"Double-blind, placebo-controlled cross-over study of intravenous S-adenosyl-L-methionine in patients with fibromyalgia","volume":"26","author":"Volkmann","year":"1997","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.bbi.2019.07.013_b0480","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00414-015-1279-y","article-title":"The pharmacology and toxicology of kratom: from traditional herb to drug of abuse","volume":"130","author":"Warner","year":"2016","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.bbi.2019.07.013_b0485","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2146\/ajhp161035","article-title":"Pharmacologic and clinical assessment of kratom","volume":"75","author":"White","year":"2018","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"10.1016\/j.bbi.2019.07.013_b0490","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.drugalcdep.2018.07.001","article-title":"Affect and cannabis use in daily life: a review and recommendations for future research","volume":"191","author":"Wycoff","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bbi.2019.07.013_b0495","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.35","article-title":"S-adenosylmethionine reduces airway inflammation and fibrosis in a murine model of chronic severe asthma via suppression of oxidative stress","volume":"48","author":"Yoon","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbi.2019.07.013_b0500","first-page":"3770","article-title":"Ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy: a multi-centered randomized controlled trial","volume":"19","author":"Zhang","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bbi.2019.07.013_b0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-neuro-070815-014038","article-title":"Beyond the CB1 receptor: is cannabidiol the answer for disorders of motivation?","volume":"39","author":"Zlebnik","year":"2016","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2019.07.013_b0510","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1096\/fj.201600646R","article-title":"Cannabinoids, inflammation, and fibrosis","volume":"30","author":"Zurier","year":"2016","journal-title":"FASEB J."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119302788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119302788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:59:14Z","timestamp":1760169554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159119302788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":102,"alternative-id":["S0889159119302788"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2019.07.013","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S-adenosyl-l-methionine (SAMe), cannabidiol (CBD), and kratom in psychiatric disorders: Clinical and mechanistic considerations","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2019.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}